Chronic administration of OB protein decreases food intake by selectively reducing meal size in male rats.
The potent hypophagic effect of OB protein (OB) is well established, but the mechanism of this effect is largely unknown. We investigated the effects of chronic administration of a novel modified recombinant human OB (Mod-OB) with a prolonged half-life (>48 h) on ad libitum food intake, spontaneous meal patterns, and body weight in 24 adult, male Sprague-Dawley rats (body weight at study onset: 292 g). Single daily subcutaneous injections of Mod-OB (4 mg/kg daily) for 8 consecutive days significantly reduced ad libitum food intake compared with vehicle injections from injection day 3 through postinjection day 3. Mod-OB-injected rats ate between 4.5 and 7.1 g (or 13-20%) per day less than controls, with the reduction primarily occurring during the dark period. Body weight gain was significantly decreased in response to Mod-OB from injection day 8 until postinjection day 4, with a maximum difference of 24 g on postinjection day 3. The reduction of food intake by Mod-OB was mainly due to a 21-34% decrease in nocturnal spontaneous meal size. There was no significant effect of Mod-OB on nocturnal meal frequency or duration. Mod-OB also did not reliably affect the size, duration, or frequency of diurnal meals. Mod-OB-injected rats displayed no compensatory hyperphagia after the injection period. These results indicate that chronically administered OB selectively affects the mechanisms controlling meal size in male rats.
Kahler
A
A
Institute for Animal Sciences, Swiss Federal Institute of Technology, 8092 Zurich, Switzerland.
Geary
N
N
Eckel
L A
LA
Campfield
L A
LA
Smith
F J
FJ
Langhans
W
W
D000818:Animals; D001066:Appetite / Q000187:drug effects* / Q000502:physiology; D001835:Body Weight / Q000187:drug effects; D004334:Drug Administration Schedule; D002149:Energy Intake / Q000187:drug effects*; D006801:Humans; D007279:Injections, Subcutaneous; D020738:Leptin; D008297:Male; D009765:Obesity; D011506:Proteins / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors
D020738:Leptin; D011506:Proteins; D011994:Recombinant Proteins